Kezar Life Sciences, Inc. (KZR) Other Operating Expenses (2023 - 2026)

Kezar Life Sciences has reported Other Operating Expenses for 3 years, with the latest figure at $12000.0 in Q1 2026.

• Quarterly Other Operating Expenses changed N/A year-over-year to $12000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (changed N/A YoY) and the FY2025 annual result came in at $5.2 million, changed N/A from the prior year.
• Other Operating Expenses retreated to $12000.0 in Q1 2026 per KZR's latest filing, from $5.2 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $5.2 million in Q4 2025 and troughed at -$13000.0 in Q4 2023.
• A 3-year average of $1.7 million and a median of $12000.0 in 2026 frame the typical range for Other Operating Expenses.